Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Pharmacogenomic implications of population admixture: Brazil as a model case.

Pharmacogenomics - 1 Feb 2014

Suarez-Kurtz Guilherme, Paula Daniela Polessa, Struchiner Claudio J

Abstract excerpt

The heterogeneous Brazilian population, with European, African and Amerindian ancestral roots is a model case for exploring the impact of population admixture on the frequency distribution of polymorphisms in pharmacogenes, and the design and interpretation of pharmacogenomics trials. Examples drawn from studies carried out by researchers of the Brazilian pharmacogenomics network, support the following...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Blood Coagulation Disorders
Share to Brazil
Share to Ethnicity

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Genetics, Population

Share to Immunosuppression Therapy

Share to Pharmacogenetics

Share to Tacrolimus

Share to Warfarin

Source

Identifiers

PMID: 24444410
DOI: 10.2217/pgs.13.238

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-07.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Pharmacogenomic implications of population admixture: Brazil as a model case.PMID 24444410Read ↗

Pharmacogenomics in the Americas: the impact of genetic admixture.Semantic proximity Read ↗

Population Diversity in Pharmacogenetics: A Latin American Perspective.Semantic proximity Read ↗

Genetic structure of pharmacogenetic biomarkers in Brazil inferred from a systematic review and population-based cohorts: a RIBEF/EPIGEN-Brazil initiative.Semantic proximity Read ↗

VKORC1 polymorphisms in Brazilians: comparison with the Portuguese and Portuguese-speaking Africans and pharmacogenetic implications.Semantic proximity Read ↗

Polymorphisms of ADME-related genes and their implications for drug safety and efficacy in Amazonian AmerindiansSemantic proximity Read ↗

Pharmacogenomics of warfarin in populations of A frican descentSemantic proximity Read ↗

Pharmacogenomics in admixed populations.Semantic proximity Read ↗

Application of the F(ST) statistics to explore pharmacogenomic diversity in the Brazilian population.Semantic proximity Read ↗

Distribution of ABCB1 polymorphisms among Brazilians: impact of population admixture.Semantic proximity Read ↗

Patterns of pharmacogenetic diversity in African populations: role of ancient and recent history.Semantic proximity Read ↗

Differential effects of predictors of warfarin dose according to race/color categories in the admixed Brazilian population.Semantic proximity Read ↗

Global pharmacogenomics: Impact of population diversity on the distribution of polymorphisms in the CYP2C cluster among Brazilians.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.